Cargando…
Human parvovirus B19 infection in an immunocompromised host
Serologic testing may be negative in immunocompromised hosts due to inadequate IgG and IgM response. The classic bone marrow findings of viral inclusions and giant proerythroblasts are pathognomonic for active infection and should prompt initiation of therapy regardless of serologic results.
Autor principal: | Pandey, Soumya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752362/ https://www.ncbi.nlm.nih.gov/pubmed/33364002 http://dx.doi.org/10.1002/ccr3.3313 |
Ejemplares similares
-
Reactive macrophage activation syndrome in a patient with parvovirus B19 infection, lymphocytic lichenoid vasculitis, urticaria and angioedema
por: Soldo-Juresa, Dragica, et al.
Publicado: (2010) -
Empyema necessitans: After recent thoracostomy in an immunocompromised patient
por: Almeida Borges, Joana, et al.
Publicado: (2023) -
Infections in the Immunocompromised Host
por: Bin-Hussain, Ibrahim
Publicado: (2012) -
Multiple nodular lesions following Pneumocystis pneumonia in a non‐HIV immunocompromised patient
por: Asakura, Takanori, et al.
Publicado: (2016) -
Recent Advances in Replication and Infection of Human Parvovirus B19
por: Ganaie, Safder S., et al.
Publicado: (2018)